This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Analysts' Actions: SIRI C ED JACK HES BBT

Stocks in this article: CEDJACKINFAHESBBTHCSGSIRI

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Astea (ATEA) upgraded to buy at TheStreet Ratings.

Berkshire Hathaway (BRK.B) upgraded to buy at TheStreet Ratings.

BB&T (BBT) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $34 price target. Valuation call, as the stock is up 32% year-to-date.

Ball (BLL) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Valuation call, based on a $44 price target.

Berry Petroleum (BRY) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $38 price target. Core California project has a muted growth outlook.

Citigroup (C) upgraded at KBW from Market Perform to Outperform, Keefe, Bruyette & Woods said. $44 price target. Fundamentals should improve and the company trades at two-thirds of its tangible book value.

CBOE (CBOE) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $27 price target. Company is facing higher costs and delaying its buyback.

Consolidated Edison (ED) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $60 price target. Company trades at a premium valuation and there are risks surrounding the company's upcoming rate case.

Fidelity National (FIS) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $35 price target. Industry faces long-term growth headwinds.

Fifth Third (FITB) downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Valuation call, as the company lacks near-term catalysts.

Healthcare Services (HCSG) downgraded at Benchmark from Buy to Hold, Benchmark said. Valuation call, based on a $23.50 price target.

Hess (HES) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Company faces capital efficiency concerns. $60 price target.

IDEX Corporation (IEX) downgraded at Oppenheimer to Perform from Outperform, Oppenheimer said. Lower organic growth prospects.

Informatica (INFA) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $31 price target. Company will struggle to achieve 2013 earnings expectations.

Jack in the Box (JACK) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Stock has made a big run versus its peers. $26 price target.

KB Home (KBH) downgraded at Citigroup to Sell from Neutral, Citigroup said. $12 price target. Agressive valuation considering leverage.

Knight Transportation (KNX) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $15 price target. Stock will likely lag its peers in the coming quarters.

Lennar (LEN) upgraded at Citigroup to Neutral from Sell, Citigroup said. $35 price target. Underperformed peers despite above average growth.

Liberty Media (LMCA) upgraded at Citigroup to Buy from Neutral, Citigroup said. $121 price target. Moving toward hard control of Sirius.

Microchip (MCHP) upgraded at ThinkEquity from Hold to Buy, ThinkEquity said. $38 price target. Recent acquisitions should add to earnings.

ON Semiconductor (ONNN) upgraded at ThinkEquity from Hold to Buy, ThinkEquity said. New CFO will drive to improve profitability. $8 price target.

Palo Alto (PANW) rated new Outperform at JMP. $77 price target. Company can capitalize on explosive demand for next-generation security.

PNC Financial (PNC) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $71 price target. Stock has lagged its peers for too long. $71 price target.

SAIC (SAI) downgraded at JP Morgan from Neutral to Underperform, JP Morgan said. $11 price target. Stock trades at a premium to its peers, even though the company still has to restructure.

Sirius XM (SIRI) rated new Buy at BofA/Merrill. $3.75 price target. Company can leverage its premier content and growing subscriber base.

Silgan (SLGN) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $44 price target. Stock should lag its peers in the coming quarters.

Safeway (SWY) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $15 price target. Expect the company to lag its peers in the coming quarters.

Integrys Energy (TEG) upgraded at DA Davidson from Neutral to Buy, DA Davidson said. $59 price target. Asset purchase should boost the rate base.

Tyler Technologies (TYL) rated new Buy at ThinkEquity. $50 price target. Company is a market leader and can continue to gain market share.

Valmont (VMI) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Valuation call, based on a $123 price target.

Wells Fargo (WFC) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $36 price target. Valuation call, as the stock is up 25% year-to-date.

WR Berkley (WRB) downgraded at Goldman to Sell, Goldman Sachs said. Valuation call, based on a $35 price target.

STOCK COMMENTS / EPS CHANGES

ARIAD Pharma (ARIA) target raised at Jefferies to $28, Jefferies said. Early AP26113 efficacy data encouraging. Buy rating.

Anheuser-Busch InBev (BUD) added to Key Call List at UBS. US top line momentum with margin upside. $94.06 price target.

Celanese (CE) numbers cut at UBS. Shares of CE now seen reaching $47, UBS said. Estimates also lowered on new growth guidance.

Generac (GNRC) estimates, target raised at BMO. Shares of GNRC now seen reaching $30, according to BMO Capital. Estimates also increased, given large power outages. Outperform rating.

International Paper (IP) numbers reduced at BMO. IP estimates were cut through 2013, BMO Capital said. Company is discounting more and seeing lower demand for pulp.

Kronos Worldwide (KRO) numbers lowered at Oppenheimer. Shares of KRO now seen reaching $20, Oppenheimer said. Estimates also lowered on ugly pre-announcement. Outperform rating.

Pentair (PNR) numbers raised at Oppenheimer. Shares of PNR now seen reaching $46, Oppenheimer said. Estimates also raised on merger possibilities. Perform rating.

Travelers (TRV) cut from Conviction Buy List at Goldman. Valuation call, based on a $75 price target.

STRATEGY CALLS / MARKET CALLS

MedTech sector upgraded at BMO. Medical Technology sector was upgraded from Market Perform to Outperform, BMO Capital said. End-markets are stabilizing and expectations appear reasonable. BAX, MDT, STJ and ZMH are among the analyst's top picks.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,380.41 +263.17 1.63%
S&P 500 1,886.76 +24.00 1.29%
NASDAQ 4,258.4380 +41.0480 0.97%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs